Ambrose J D, Kastelic J P, Rajamahendran R, Aali M, Dinn N
Livestock Development Division, Alberta Agriculture Food and Rural Development, Suite 205, 6903-116 Street, Edmonton, Alta., Canada T6H 5Z2.
Theriogenology. 2005 Oct 15;64(7):1457-74. doi: 10.1016/j.theriogenology.2005.03.010. Epub 2005 Apr 14.
The overall objective was to compare the efficacy of GnRH, porcine LH (pLH) and estradiol cypionate (ECP), in a modified Ovsynch/fixed-time AI (FTAI) protocol that included a controlled internal drug [progesterone] release (CIDR) device. In Experiment 1, heifers received a CIDR on Day -10, and PGF (25mg) on Day -3. At CIDR insertion, heifers received 100 microg of GnRH (n=6), 0.5mg of ECP (n=6), 5.0mg of pLH (n=6) or 2 mL of saline (n=7); these treatments were repeated on Day -1, except for ECP, that was repeated on Day -2, concurrent with CIDR-removal. The 5.0 mg pLH was the least effective with a longer interval to ovulation than the other groups combined (102 versus 64 h; P<0.05). Overall mean LH concentrations (1.6 ng/mL) and area under the curve (AUC) did not differ among treatments, but mean peak LH concentration was lower in heifers given 5 mg of pLH compared to all other groups (4.5 versus 10.3 ng/mL; P<0.05). In Experiment 2, heifers on CIDR-based Ovsynch protocols were given 12.5mg pLH (n=6; pLH-low), 25.0 mg pLH (n=6, pLH-high), or 100 microg GnRH (n=5; control). Heifers in the pLH-high group had greater (P<0.01) plasma LH concentrations (between 12 and 20 h) than GnRH-treated heifers, but the pLH treatments did not differ (P>0.10). Area under the curve for LH (ng/32 h) was at least 50% greater (P<0.01) in pLH-treated heifers compared to GnRH-treated heifers (mean, 41.3, 56.3 and 20.3 for pLH-low, pLH-high and GnRH, respectively). Ovulation occurred in 15 of 17 heifers. Progesterone concentrations were higher on Days 9 and 14 in heifers given 25mg of pLH, suggesting enhanced CL function. In Experiment 3, 240 heifers were assigned to CIDR-based Ovsynch/FTAI protocols. The first and second hormonal treatments (with an intervening PGF treatment on Day -3) were GnRH/GnRH (100 microg), ECP/ECP (0.5 mg), pLH/pLH (12.5 mg) or GnRH/ECP, respectively; pregnancy rates were 58.7, 66.1, 45.9 and 48.3%, respectively (ECP/ECP>both pLH/pLH and GnRH/ECP; P<or=0.05). In conclusion, CIDR-based Ovsynch/FTAI protocols using either GnRH/GnRH or ECP/ECP yielded pregnancy rates about 20% points higher than previously reported for dairy heifers bred to Ovsynch/FTAI in the absence of a CIDR.
总体目标是在一种改良的同期发情/定时人工授精(FTAI)方案中比较促性腺激素释放激素(GnRH)、猪促黄体素(pLH)和环丙孕酮(ECP)的疗效,该方案包括一个可控的内部药物[孕酮]释放(CIDR)装置。在实验1中,小母牛在第-10天接受CIDR,在第-3天接受前列腺素F2α(PGF,25mg)。在插入CIDR时,小母牛接受100微克GnRH(n = 6)、0.5毫克ECP(n = 6)、5.0毫克pLH(n = 6)或2毫升生理盐水(n = 7);这些处理在第-1天重复,但ECP在第-2天重复,与取出CIDR同时进行。5.0毫克pLH效果最差,排卵间隔时间比其他组总和更长(102小时对64小时;P<0.05)。各处理间总体平均促黄体素(LH)浓度(1.6纳克/毫升)和曲线下面积(AUC)无差异,但给予5毫克pLH的小母牛平均促黄体素峰值浓度低于所有其他组(4.5纳克/毫升对10.3纳克/毫升;P<0.05)。在实验2中,基于CIDR的同期发情方案中的小母牛接受12.5毫克pLH(n = 6;低剂量pLH组)、25.0毫克pLH(n = 6;高剂量pLH组)或100微克GnRH(n = 5;对照组)。高剂量pLH组小母牛在12至20小时之间的血浆促黄体素浓度高于GnRH处理的小母牛(P<0.01),但pLH各处理间无差异(P>0.10)。与GnRH处理的小母牛相比,pLH处理的小母牛促黄体素曲线下面积(纳克/32小时)至少高50%(P<0.01)(低剂量pLH组、高剂量pLH组和GnRH组的平均值分别为41.3、56.3和20.3)。17头小母牛中有15头排卵。给予25毫克pLH的小母牛在第9天和第14天孕酮浓度较高,表明黄体功能增强。在实验3中,240头小母牛被分配到基于CIDR的同期发情/FTAI方案中。第一次和第二次激素处理(中间在第-3天进行PGF处理)分别为GnRH/GnRH(100微克)、ECP/ECP(0.5毫克)、pLH/pLH(12.5毫克)或GnRH/ECP;妊娠率分别为58.7%、66.1%、45.9%和48.3%(ECP/ECP组高于pLH/pLH组和GnRH/ECP组;P≤0.05)。总之,使用GnRH/GnRH或ECP/ECP的基于CIDR的同期发情/FTAI方案产生的妊娠率比之前报道的在没有CIDR的情况下对同期发情/FTAI的奶牛小母牛的妊娠率高出约20个百分点。